GBLX - GB Sciences says cannabinoid mixtures could potentially treat Parkinson's disease

• Research conducted by GB Sciences ( OTCQB:GBLX ) indicates that a mixture of cannabinoids could potentially provide therapeutic benefits in the treatment of Parkinson's disease.
• The company said that "cannabis-inspired compounds" were effective in reducing Parkinsonian motor symptoms in an animal model of the disease.
• The research was published in the journal Frontiers in Pharmacology .
• GB's ( OTCQB:GBLX ) cannibinoid mixtures for Parkinson's are patented .

For further details see: